Veronica Galvan

11PUBLICATIONS
35CO-AUTHORS
Medical devicesNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Molecular targetsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 24, 2026
mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimer's disease.

|Sep 24, 2026
Soluble pathogenic tau transmission to astrocytes drives cellular senescence and neurovascular uncoupling in a model of Alzheimer's tauopathy.

|Jul 03, 2026
mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimers disease with cerebral amyloid angiopathy.

|May 12, 2026
Regulation of survival, growth, and metabolism by neuronal mTOR.

|May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial.

Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz

|May 15, 2023
Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy.

Stacy A Hussong, Andy Q Banh, Candice E Van Skike

Pageof 2

Frequent Collaborators

3 joint publications

Stacy Hussong

3 joint publications

Haneen Makhlouf

3 joint publications

Candice E Van Skike

3 joint publications

Stephen Hernandez